What insurance policy changes affect Cardiology providers?

Cardiology providers face policy updates from major payers including prior authorization requirements, billing code changes, reimbursement rate adjustments, and coverage criteria revisions. PolicyChanges.app tracks these updates daily across all major insurers.

How often do insurance policies change for Cardiology?

Insurance payers publish policy changes on rolling schedules: some quarterly, some monthly, and some with immediate effect. Cardiology practices typically see dozens of relevant changes per year across their contracted payers.

How do I get notified of new Cardiology policy changes?

Sign up for a free PolicyChanges.app account and create a saved search filtered to Cardiology. You will receive a daily digest whenever a new policy change matches your specialty filter.

Which payers post the most policy changes affecting Cardiology?

Based on tracked changes, Cardiology updates have come from payers including BCBS Texas, UnitedHealthcare.

Cardiology Insurance Policy Changes

Keeping up with insurance policy changes that affect Cardiology practices is a full-time job. This page aggregates the latest payer updates (prior authorization rule changes, reimbursement adjustments, billing code additions and removals, and coverage policy revisions) across all major insurers. Changes are identified and summarized daily so Cardiology providers and their billing teams can act before deadlines pass.

Low impact
Quality Measures Help Track Our Members’ Heart Health
BCBS Texas·Effective Jan 23, 2026
Blue Cross Blue Shield of Texas has published quality measure tracking guidelines for heart health, focusing on blood pressure control (systolic <140, diastolic <90) for members ages 18-85 with hypertension, and statin therapy compliance for cardiovascular disease patients. This is informational guidance to help providers identify care gaps and improve documentation.
Medium impact
New radiology and cardiology prior authorization codes
UnitedHealthcare·Effective Apr 1, 2026
Starting April 1, 2026, UnitedHealthcare will require prior authorization for 5 new radiology codes (including CT cerebral perfusion and brain MRI analysis) and 8 new cardiology codes (primarily dual chamber and leadless pacemaker procedures) across most commercial and Medicaid plans, but not Medicare Advantage plans.
Medium impact
Review the 2026 Administrative Guide
UnitedHealthcare·Effective Apr 1, 2026
UnitedHealthcare has released the 2026 Provider Administrative Guide with updates effective April 1, 2026 for existing providers (90-day review period) and January 1, 2026 for newly contracted providers. Key changes include removal of prior authorization requirements for several radiology and cardiology services, updated discharge notification and facility transfer requirements, preferred diabetic supply brands, and revised timely filing requirements for corrected claims.
Low impact
Women’s Health Month: Not all heart attacks look the same
UnitedHealthcare·Identified Jun 3, 2026
This is an educational article about recognizing atypical heart attack symptoms in women, not a policy change. UnitedHealthcare published this as part of Women's Health Month to help providers understand that women often present with subtle symptoms like back, neck, jaw, or abdominal pain rather than classic chest pain.
Medium impact
New genetic and molecular codes required for prior authorization
UnitedHealthcare·Effective Jul 1, 2026
UnitedHealthcare is adding 10 new genetic and molecular testing procedure codes (0616U-0628U) to their prior authorization requirements, effective July 1, 2026. This affects specific commercial and Individual Exchange plans across all states.
Medium impact
Medicaid: View new genetic and molecular code updates
UnitedHealthcare·Effective Jul 1, 2026
UnitedHealthcare is updating prior authorization and advance notification requirements for genetic and molecular procedure codes effective July 1, 2026, to comply with American Medical Association code changes. This affects multiple UnitedHealthcare Community Plans across 18 states.
Medium impact
Medicaid: Prior authorization required for certain transcatheter heart valve procedures
UnitedHealthcare·Effective Jul 1, 2026
Starting July 1, 2026, UnitedHealthcare Community Plans (Medicaid) will require prior authorization for transcatheter heart valve procedures using codes 0569T and 0570T. These codes were previously classified as unproven but are now considered proven in certain clinical circumstances requiring medical necessity review.
Medium impact
New codes added to outpatient radiology prior authorization program
UnitedHealthcare·Effective Sep 1, 2026
Beginning September 1, 2026, UnitedHealthcare will add two new imaging codes (CPT 70471 and 75577) to their outpatient radiology prior authorization program. These additions affect commercial plans, Community Plans, Individual Exchange Plans, Oxford Plans, and Rocky Mountain Health Plans, but do not apply to Medicare Advantage or Dual Special Needs Plans.
Low impact
RNA-Targeted Therapies (Amvuttra ® and Onpattro ® )
UnitedHealthcare·Effective Jun 1, 2026
UnitedHealthcare updated their Medical Benefit Drug Policy for RNA-targeted therapies Amvuttra and Onpattro effective June 1, 2026. This policy change affects coverage criteria and billing requirements for these specialized hereditary transthyretin amyloidosis medications.
Medium impact
[New York] Genetic testing claims for FEP members: medical records required for review
Anthem BCBS·Identified May 29, 2026
FEP (Federal Employee Program) members now require medical records to be submitted for genetic testing claim reviews. This affects all genetic testing claims for federal employees and requires additional documentation beyond standard claims submission.
Low impact
[Ohio] Automated Blood Pressure Cuffs - A4670
CareSource·Identified May 9, 2026
CareSource has issued a policy bulletin regarding automated blood pressure cuffs using HCPCS code A4670. The policy appears to provide guidance on coverage or billing requirements for these devices under Medicaid programs.
Medium impact
[Indiana] Modifiers JZ and JW
CareSource·Identified May 9, 2026
CareSource Indiana has issued guidance on the proper use of modifiers JZ and JW for drug wastage reporting. These modifiers are required when billing for certain medications to indicate whether drug wastage occurred during administration.
Medium impact
[Georgia] CareSource Cardiac and Musculoskeletal Surgical Quality and Safety Management Program in Partnership with TurningPoint
CareSource·Identified May 9, 2026
CareSource Georgia has implemented a new Cardiac and Musculoskeletal Surgical Quality and Safety Management Program in partnership with TurningPoint. This program will likely introduce quality measures, review processes, or management protocols for cardiac and orthopedic surgical procedures for CareSource members.
Low impact
[California] Statin Use in Persons with Diabetes: closing the statin gap for adults aged 40 to 75 with diabetes
Anthem BCBS·Identified May 3, 2026
Anthem California has issued a provider bulletin focused on closing the statin therapy gap for adults aged 40-75 with diabetes. This appears to be an educational initiative to improve statin prescribing rates in diabetic patients rather than a billing policy change.
Medium impact
[New York] Statin Use in Persons with Diabetes: closing the statin gap for adults aged 40 to 75 with diabetes
Anthem BCBS·Identified May 3, 2026
Anthem has issued a provider bulletin focused on improving statin prescribing for diabetic patients aged 40-75 to close care gaps. This is likely part of a quality measure initiative that may affect provider performance metrics and potentially reimbursement rates.
Medium impact
[Virginia] Important update on two‑stage compression device authorizations
Anthem BCBS·Identified May 3, 2026
Virginia Anthem has issued an important update regarding authorization requirements for two-stage compression devices. This change affects the prior authorization process for these medical devices used in treating various conditions requiring compression therapy.
Low impact
[Virginia] Statin Use in Persons with Diabetes: closing the statin gap for adults aged 40 to 75 with diabetes
Anthem BCBS·Identified May 3, 2026
This is a provider bulletin focusing on increasing statin prescribing rates for adults aged 40-75 with diabetes to improve clinical outcomes. This appears to be an educational/quality improvement initiative rather than a billing policy change.
Low impact
New Data on Quality Measures for Reporting Year 2024
BCBS Texas·Identified May 3, 2026
Blue Cross Blue Shield Texas released 2024 quality measure performance data showing improvements across HEDIS measures like blood pressure control, cancer screenings, and diabetes management for commercial HMO, PPO, and marketplace plans. This is informational data about member outcomes and does not change billing requirements or procedures.
Medium impact
Prior Authorization Changes for Some Commercial and Government Program Members, Effective April 1, 2026
BCBS Texas·Effective Apr 1, 2026
Blue Cross Blue Shield of Texas is removing prior authorization requirements for psychological/neuropsychological testing codes for commercial members and replacing revascularization codes that require prior auth for Medicare Advantage members. Changes take effect April 1, 2026.
Medium impact
Access Resource on 2026 Quality Measures in Availity® Essentials
BCBS Texas·Effective Mar 11, 2026
Blue Cross Blue Shield of Texas has released a 2026 Quality Care resource in Availity Essentials containing HEDIS quality measure codes for documentation and coding. The resource includes CPT, HCPCS, and ICD-10 codes for behavioral health, cancer screening, diabetes care, immunizations, and other preventive services to help close care gaps.
Medium impact
Prior Authorization Changes for Some Government Program Members
BCBS Texas·Effective Jul 1, 2026
Blue Cross Blue Shield of Texas is changing prior authorization requirements for Medicare Advantage and Medicaid members effective July and August 2026. Some cardiology and lab codes will no longer require prior authorization, while new miscellaneous codes will be added to the prior auth requirement list.
Medium impact
Early prevention: New implications for high blood pressure management
Cigna·Identified May 1, 2026
New joint guidelines from ACC/AHA emphasize earlier intervention for high blood pressure, particularly for younger patients under 45. The guidelines lower intervention thresholds and expand medication recommendations, likely increasing the number of younger patients qualifying for treatment and affecting billing for hypertension management services.
Medium impact
Prescribing Provider Survey for the Texas Prescription Monitoring Program Due May 11, 2026
Texas Medicaid·Effective May 11, 2026
The Texas Health and Human Services Commission requires all Texas Medicaid-enrolled prescribing providers to complete a survey about their use of the Texas Prescription Drug Monitoring Program (PDMP) for controlled substance prescriptions. This survey covers prescription data from federal fiscal year 2025 and must be completed by May 11, 2026.
Low impact
March 11, 2026 Managing blood pressure may change breast cancer outlook A large study finds lower death rates among women with advanced breast …
Kaiser Permanente·Identified Mar 31, 2026
This appears to be a news article about a medical study linking blood pressure management to breast cancer outcomes, not an insurance policy change. The content is from Kaiser Permanente's health news section and does not contain billing, coding, or coverage policy updates.
Low impact
Integrating dental, mental, and chronic care for overall wellness
Cigna·Identified Mar 31, 2026
Cigna Healthcare is promoting integration of dental, mental, and chronic care for overall wellness. The policy highlights bidirectional relationships between oral health and chronic conditions like diabetes, heart disease, and mental health disorders, emphasizing the need for coordinated care approaches.
Medium impact
New Genetic Testing Benefits for Texas Medicaid Effective May 1, 2026
Texas Medicaid·Effective May 1, 2026
Texas Medicaid is adding new genetic testing benefits effective May 1, 2026, including whole exome sequencing, FoundationOne cancer testing, transplant rejection monitoring, ClonoSEQ testing for blood cancers, enhanced liver fibrosis testing, and breast cancer index testing. All these new tests require prior authorization and have specific medical necessity criteria and frequency limitations.
Medium impact
Correction to “Pharmacogenetics” in the Medical and Nursing Specialists, Physicians, and Physician Assistants Handbook
Texas Medicaid·Identified Mar 14, 2026
TMHP corrected errors in the Texas Medicaid handbook for pharmacogenetics testing: the correct gene code is 2C19 (not 2C9) and the correct procedure code is 81225 (not 81227). These corrections will be officially updated in the April TMPPM release.
Medium impact
Update to “Correction to ‘Reimbursement Rate Changes and Updates for Certain Texas Medicaid Procedure Codes Effective September 1, 2025’”
Texas Medicaid·Effective Sep 1, 2025
Texas Medicaid corrected reimbursement rates for cardiovascular services at rural hospitals, with multiple procedure categories getting updated rates effective September 1, 2025. TMHP will automatically reprocess affected claims and adjustments will appear on future remittance reports.
Medium impact
Annual Review: CPCP030 Point-of-Care Ultrasound (POCUS) Examination Policy Updated
BCBS Texas·Effective Jan 7, 2025
Blue Cross Blue Shield of Texas has updated the CPCP030 Point-of-Care Ultrasound (POCUS) Examination Policy, which contains new clinical payment and coding guidelines for ultrasound procedures performed at the point of care. The revised policy becomes effective January 7, 2025.
High impact
Prior Authorization Code Changes for Commercial Members Effective April 1, 2025
BCBS Texas·Effective Apr 1, 2025
Blue Cross Blue Shield of Texas is updating prior authorization requirements for commercial members effective April 1, 2025. Multiple specialty areas will have codes added or removed from prior authorization lists, including cardiology, genetic testing, musculoskeletal, medical oncology, and specialty pharmacy codes.
Low impact
Quality Measures Help Track Our Members’ Heart Health
BCBS Texas·Effective Jan 21, 2025
Blue Cross Blue Shield of Texas issued guidance on quality measures for tracking heart health, focusing on blood pressure control for hypertensive patients ages 18-85 and statin therapy for cardiovascular disease patients. This is informational guidance about quality metrics rather than billing requirements.
Medium impact
Utilization Management Review Paused for Advanced Imaging Site of Care
BCBS Texas·Effective Feb 7, 2025
Blue Cross Blue Shield of Texas has paused expanded utilization management reviews for Advanced Imaging Site of Care services that were scheduled to begin January 1, 2025. This pause does not affect prior authorization requirements for medical necessity reviews of advanced imaging procedures.
Low impact
New Data on Quality Measures for Reporting Year 2023
BCBS Texas·Identified Jan 12, 2026
Blue Cross Blue Shield of Texas released 2023 quality measures data showing improvement in HEDIS measures across commercial HMO, PPO, and marketplace plans. This is informational reporting that highlights areas where providers can help close care gaps in preventive screenings and chronic care management.
Medium impact
Quality Measures Track Diabetes Care
BCBS Texas·Effective May 13, 2025
This policy outlines HEDIS quality measures that Blue Cross Blue Shield of Texas tracks for diabetes care, including glycemic status, blood pressure control, eye exams, kidney health evaluations, and statin therapy. Providers should focus on proper documentation using CPT II codes and ensuring comprehensive diabetes care to meet quality benchmarks.
Low impact
Encourage Our Members to Adhere to Statin Therapy As Prescribed
BCBS Texas·Effective Sep 11, 2025
Blue Cross Blue Shield Texas has issued guidance encouraging providers to help members adhere to statin therapy prescriptions to meet NCQA quality measures. The policy provides recommendations for improving statin adherence rates for patients with cardiovascular disease and diabetes but does not appear to change billing requirements.
Medium impact
Medical Records Collection for Federal Employee Program® Begins in February
BCBS Texas·Effective Feb 1, 2026
Blue Cross Blue Shield Federal Employee Program (FEP) will begin collecting medical records from providers caring for FEP members from February through April 2026 for HEDIS quality measures. Providers must respond to medical record requests from BCBS FEP or their vendor Advantmed within 5 business days.
Medium impact
Updated documentation guidelines for cardiac ablation procedures
UnitedHealthcare·Effective Jan 1, 2026
Beginning January 1, 2026, UnitedHealthcare will require additional medical documentation for prior authorization requests for cardiac ablation procedures (CPT codes 93653 and 93656). The new requirements include ECG/rhythm documentation, recent physical exams, lab results, imaging studies, and failed treatment history.
Medium impact
No prior authorizations required for some radiology and cardiology procedures
UnitedHealthcare·Effective Jan 1, 2026
Starting January 1, 2026, UnitedHealthcare will eliminate prior authorization requirements for certain nuclear imaging, obstetrical ultrasound, and echocardiogram procedures across multiple plan types. This change aims to simplify the healthcare experience for providers and members by removing administrative barriers for these specific radiology and cardiology procedures.
Medium impact
Medicare: Vyndaqel will be discontinued on Dec. 31
UnitedHealthcare·Effective Dec 31, 2025
Pfizer is discontinuing Vyndaqel (tafamidis meglumine) effective December 31, 2025 for treating transthyretin amyloid cardiomyopathy. UnitedHealthcare Medicare Advantage and Part D plans will cover Vyndamax (tafamidis) as the alternative, and existing Vyndaqel prior authorizations can transition to Vyndamax without requiring new authorization.
High impact
New DME process for select members in multiple states
UnitedHealthcare·Effective Apr 1, 2026
Beginning April 1, 2026, Synapse Health will manage durable medical equipment (DME) ordering and fulfillment for UnitedHealthcare Medicare Advantage plans in multiple states. DME prescribers must use Synapse Health's e-prescribing portal, and DME providers must join the Synapse Health network to continue serving these members.
Medium impact
Review the 2026 Administrative Guide
UnitedHealthcare·Effective Apr 1, 2026
UnitedHealthcare has released the 2026 Provider Administrative Guide with several key changes including removal of prior authorization requirements for multiple radiology and cardiology services, updated discharge notification requirements, and revised timely filing requirements for corrected claims.
High impact
New radiology and cardiology prior authorization codes
UnitedHealthcare·Effective Apr 1, 2026
Starting April 1, 2026, UnitedHealthcare will require prior authorization for new radiology and cardiology procedure codes, including CT brain perfusion analysis, brain MRI quantitative analysis, nuclear cardiology blood flow analysis, and various leadless pacemaker procedures. This affects commercial plans, Community Plans, Exchange Plans, Oxford Plans, and Rocky Mountain Health Plans, but excludes Medicare Advantage and D-SNP plans.

Family Medicine Internal Medicine Pediatrics Anthem BCBS CareSource Texas Medicaid UnitedHealthcare BCBS Texas TX OH GA CA

Get alerts for changes like this

Save a search and receive a daily digest whenever a new policy change matches your filters.

Create a free alert

Quality Measures Help Track Our Members’ Heart Health

New radiology and cardiology prior authorization codes

Review the 2026 Administrative Guide

Women’s Health Month: Not all heart attacks look the same

New genetic and molecular codes required for prior authorization

Medicaid: View new genetic and molecular code updates

Medicaid: Prior authorization required for certain transcatheter heart valve procedures

New codes added to outpatient radiology prior authorization program

RNA-Targeted Therapies (Amvuttra ® and Onpattro ® )

[New York] Genetic testing claims for FEP members: medical records required for review

[Ohio] Automated Blood Pressure Cuffs - A4670

[Indiana] Modifiers JZ and JW

[Georgia] CareSource Cardiac and Musculoskeletal Surgical Quality and Safety Management Program in Partnership with TurningPoint

[California] Statin Use in Persons with Diabetes: closing the statin gap for adults aged 40 to 75 with diabetes

[New York] Statin Use in Persons with Diabetes: closing the statin gap for adults aged 40 to 75 with diabetes

[Virginia] Important update on two‑stage compression device authorizations

[Virginia] Statin Use in Persons with Diabetes: closing the statin gap for adults aged 40 to 75 with diabetes

New Data on Quality Measures for Reporting Year 2024

Prior Authorization Changes for Some Commercial and Government Program Members, Effective April 1, 2026

Access Resource on 2026 Quality Measures in Availity® Essentials

Prior Authorization Changes for Some Government Program Members

Early prevention: New implications for high blood pressure management

Prescribing Provider Survey for the Texas Prescription Monitoring Program Due May 11, 2026

March 11, 2026 Managing blood pressure may change breast cancer outlook A large study finds lower death rates among women with advanced breast …

Integrating dental, mental, and chronic care for overall wellness

New Genetic Testing Benefits for Texas Medicaid Effective May 1, 2026

Correction to “Pharmacogenetics” in the Medical and Nursing Specialists, Physicians, and Physician Assistants Handbook

Update to “Correction to ‘Reimbursement Rate Changes and Updates for Certain Texas Medicaid Procedure Codes Effective September 1, 2025’”

Annual Review: CPCP030 Point-of-Care Ultrasound (POCUS) Examination Policy Updated

Prior Authorization Code Changes for Commercial Members Effective April 1, 2025

Quality Measures Help Track Our Members’ Heart Health

Utilization Management Review Paused for Advanced Imaging Site of Care

New Data on Quality Measures for Reporting Year 2023

Quality Measures Track Diabetes Care

Encourage Our Members to Adhere to Statin Therapy As Prescribed

Medical Records Collection for Federal Employee Program® Begins in February

Updated documentation guidelines for cardiac ablation procedures

No prior authorizations required for some radiology and cardiology procedures

Medicare: Vyndaqel will be discontinued on Dec. 31

New DME process for select members in multiple states

Review the 2026 Administrative Guide

New radiology and cardiology prior authorization codes